Page last updated: 2024-09-03

san 202791 and pituitrin

san 202791 has been researched along with pituitrin in 1 studies

Compound Research Comparison

Studies (san 202791)	Trials (san 202791)	Recent Studies (post-2010) (san 202791)	Studies (pituitrin)	Trials (pituitrin)	Recent Studies (post-2010) (pituitrin)
31	0	2	22,137	594	2,101

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
de Ree, MM; Gähwiler, BH; Knot, HJ; Rüegg, UT	1

Other Studies

1 other study(ies) available for san 202791 and pituitrin

Article	Year
Modulation of electrical activity and of intracellular calcium oscillations of smooth muscle cells by calcium antagonists, agonists, and vasopressin. Journal of cardiovascular pharmacology, 1991, Volume: 18 Suppl 10 Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Animals; Calcium; Calcium Channel Agonists; Calcium Channel Blockers; Cells, Cultured; Dihydropyridines; Isradipine; Membrane Potentials; Muscle, Smooth, Vascular; Rats; Vasopressins	1991

Article

Year

Modulation of electrical activity and of intracellular calcium oscillations of smooth muscle cells by calcium antagonists, agonists, and vasopressin.

Journal of cardiovascular pharmacology, 1991, Volume: 18 Suppl 10

Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Animals; Calcium; Calcium Channel Agonists; Calcium Channel Blockers; Cells, Cultured; Dihydropyridines; Isradipine; Membrane Potentials; Muscle, Smooth, Vascular; Rats; Vasopressins

1991